Workflow
Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health

Company Overview - YourBio Health is a medical device company focused on revolutionizing blood collection through its Touch-Activated Phlebotomy (TAP®) technology, which is the first push-button blood collection system [10] - The TAP products utilize microneedles for virtually painless blood draws and are applicable in clinical trials, diagnostics, and wellness settings, enabling reliable at-home blood collection [3][10] - YourBio Health was founded by Flagship Pioneering in 2011 and aims to humanize and decentralize the blood collection process [10] Leadership Appointment - Paul Owen has been appointed as the Chief Executive Officer of YourBio Health and CEO-Partner of Flagship Pioneering, bringing over 35 years of corporate leadership and strategic planning experience [1][2][5] - Owen's previous roles include Board Director and President of Oncodea, Managing Partner for Trusted Health Advisors, and leadership positions at imaware™, OneOme, and Mayo Medical Laboratories [2][6][7] - His strategic vision is expected to drive growth and innovation at YourBio Health, particularly in enhancing the blood collection experience for patients and healthcare providers [3][4] Market Potential - There is significant potential in simplifying blood collection to improve disease treatment and prevention, with the company poised to leverage its technology for broader applications in the healthcare industry [4] - Since its commercial launch, TAP devices have been utilized in multiple clinical trials and have facilitated millions of blood collections, indicating strong market acceptance and utility [3] Flagship Pioneering Overview - Flagship Pioneering is a bioplatform innovation company that has created over 100 scientific ventures since its inception in 2000, resulting in more than $60 billion in aggregate value [9] - The company currently manages $14 billion in assets and has a diverse ecosystem of over 40 companies, including notable names like Moderna and Sana Biotechnology [9]